Long-term effects of epalrestat, an aldose reductase inhibitor, on diabetic peripheral neuropathy : a 3-yr multicenter comparative study, ARI-diabetes complication trial (ADCT)
収録刊行物
-
- Diabetes
-
Diabetes 54 (1), A213-, 2005